The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Amphotericin B Market Research Report 2024
Synopsis
Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL in vitro. While Candida albicans is generally quite susceptible to amphotericin B, non-albicans species may be less susceptible. Pseudallescheria boydii and Fusarium sp. are often resistant to amphotericin B. The antibiotic is without effect on bacteria, rickettsiae, and viruses.
The global Amphotericin B market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amphotericin B is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amphotericin B is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Amphotericin B in Vaginitis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Amphotericin B include Bristol-Myers Squibb, Matinas BioPharma, Nanox, Nanomerics, DNDi, Abzena, Bharat Serums, Jina Pharma and Astellas Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amphotericin B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amphotericin B.
Report Scope
The Amphotericin B market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amphotericin B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amphotericin B companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Matinas BioPharma
Nanox
Nanomerics
DNDi
Abzena
Bharat Serums
Jina Pharma
Astellas Pharma
Leadiant Biosciences
Kadmon Corporation (Eli Lilly and Company)
InterMune
Sterimax Inc
X-GEN Pharmaceuticals
Segment by Type
Static Drops
Atomization Inhalation
Local Lesion Injection
Other
Segment by Application
Vaginitis
Candida Infection
Leishmaniasis
Kala-Azar
Cryptococcal Infection
Aspergillus Infection
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amphotericin B companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL in vitro. While Candida albicans is generally quite susceptible to amphotericin B, non-albicans species may be less susceptible. Pseudallescheria boydii and Fusarium sp. are often resistant to amphotericin B. The antibiotic is without effect on bacteria, rickettsiae, and viruses.
The global Amphotericin B market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amphotericin B is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amphotericin B is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Amphotericin B in Vaginitis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Amphotericin B include Bristol-Myers Squibb, Matinas BioPharma, Nanox, Nanomerics, DNDi, Abzena, Bharat Serums, Jina Pharma and Astellas Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amphotericin B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amphotericin B.
Report Scope
The Amphotericin B market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amphotericin B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amphotericin B companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Matinas BioPharma
Nanox
Nanomerics
DNDi
Abzena
Bharat Serums
Jina Pharma
Astellas Pharma
Leadiant Biosciences
Kadmon Corporation (Eli Lilly and Company)
InterMune
Sterimax Inc
X-GEN Pharmaceuticals
Segment by Type
Static Drops
Atomization Inhalation
Local Lesion Injection
Other
Segment by Application
Vaginitis
Candida Infection
Leishmaniasis
Kala-Azar
Cryptococcal Infection
Aspergillus Infection
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amphotericin B companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amphotericin B Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Static Drops
1.2.3 Atomization Inhalation
1.2.4 Local Lesion Injection
1.2.5 Other
1.3 Market by Application
1.3.1 Global Amphotericin B Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Vaginitis
1.3.3 Candida Infection
1.3.4 Leishmaniasis
1.3.5 Kala-Azar
1.3.6 Cryptococcal Infection
1.3.7 Aspergillus Infection
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Amphotericin B Market Perspective (2019-2030)
2.2 Amphotericin B Growth Trends by Region
2.2.1 Global Amphotericin B Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Amphotericin B Historic Market Size by Region (2019-2024)
2.2.3 Amphotericin B Forecasted Market Size by Region (2025-2030)
2.3 Amphotericin B Market Dynamics
2.3.1 Amphotericin B Industry Trends
2.3.2 Amphotericin B Market Drivers
2.3.3 Amphotericin B Market Challenges
2.3.4 Amphotericin B Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Amphotericin B Players by Revenue
3.1.1 Global Top Amphotericin B Players by Revenue (2019-2024)
3.1.2 Global Amphotericin B Revenue Market Share by Players (2019-2024)
3.2 Global Amphotericin B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Amphotericin B Revenue
3.4 Global Amphotericin B Market Concentration Ratio
3.4.1 Global Amphotericin B Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amphotericin B Revenue in 2023
3.5 Amphotericin B Key Players Head office and Area Served
3.6 Key Players Amphotericin B Product Solution and Service
3.7 Date of Enter into Amphotericin B Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Amphotericin B Breakdown Data by Type
4.1 Global Amphotericin B Historic Market Size by Type (2019-2024)
4.2 Global Amphotericin B Forecasted Market Size by Type (2025-2030)
5 Amphotericin B Breakdown Data by Application
5.1 Global Amphotericin B Historic Market Size by Application (2019-2024)
5.2 Global Amphotericin B Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Amphotericin B Market Size (2019-2030)
6.2 North America Amphotericin B Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Amphotericin B Market Size by Country (2019-2024)
6.4 North America Amphotericin B Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Amphotericin B Market Size (2019-2030)
7.2 Europe Amphotericin B Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Amphotericin B Market Size by Country (2019-2024)
7.4 Europe Amphotericin B Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Amphotericin B Market Size (2019-2030)
8.2 Asia-Pacific Amphotericin B Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Amphotericin B Market Size by Region (2019-2024)
8.4 Asia-Pacific Amphotericin B Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Amphotericin B Market Size (2019-2030)
9.2 Latin America Amphotericin B Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Amphotericin B Market Size by Country (2019-2024)
9.4 Latin America Amphotericin B Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Amphotericin B Market Size (2019-2030)
10.2 Middle East & Africa Amphotericin B Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Amphotericin B Market Size by Country (2019-2024)
10.4 Middle East & Africa Amphotericin B Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Detail
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Amphotericin B Introduction
11.1.4 Bristol-Myers Squibb Revenue in Amphotericin B Business (2019-2024)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Matinas BioPharma
11.2.1 Matinas BioPharma Company Detail
11.2.2 Matinas BioPharma Business Overview
11.2.3 Matinas BioPharma Amphotericin B Introduction
11.2.4 Matinas BioPharma Revenue in Amphotericin B Business (2019-2024)
11.2.5 Matinas BioPharma Recent Development
11.3 Nanox
11.3.1 Nanox Company Detail
11.3.2 Nanox Business Overview
11.3.3 Nanox Amphotericin B Introduction
11.3.4 Nanox Revenue in Amphotericin B Business (2019-2024)
11.3.5 Nanox Recent Development
11.4 Nanomerics
11.4.1 Nanomerics Company Detail
11.4.2 Nanomerics Business Overview
11.4.3 Nanomerics Amphotericin B Introduction
11.4.4 Nanomerics Revenue in Amphotericin B Business (2019-2024)
11.4.5 Nanomerics Recent Development
11.5 DNDi
11.5.1 DNDi Company Detail
11.5.2 DNDi Business Overview
11.5.3 DNDi Amphotericin B Introduction
11.5.4 DNDi Revenue in Amphotericin B Business (2019-2024)
11.5.5 DNDi Recent Development
11.6 Abzena
11.6.1 Abzena Company Detail
11.6.2 Abzena Business Overview
11.6.3 Abzena Amphotericin B Introduction
11.6.4 Abzena Revenue in Amphotericin B Business (2019-2024)
11.6.5 Abzena Recent Development
11.7 Bharat Serums
11.7.1 Bharat Serums Company Detail
11.7.2 Bharat Serums Business Overview
11.7.3 Bharat Serums Amphotericin B Introduction
11.7.4 Bharat Serums Revenue in Amphotericin B Business (2019-2024)
11.7.5 Bharat Serums Recent Development
11.8 Jina Pharma
11.8.1 Jina Pharma Company Detail
11.8.2 Jina Pharma Business Overview
11.8.3 Jina Pharma Amphotericin B Introduction
11.8.4 Jina Pharma Revenue in Amphotericin B Business (2019-2024)
11.8.5 Jina Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Detail
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Amphotericin B Introduction
11.9.4 Astellas Pharma Revenue in Amphotericin B Business (2019-2024)
11.9.5 Astellas Pharma Recent Development
11.10 Leadiant Biosciences
11.10.1 Leadiant Biosciences Company Detail
11.10.2 Leadiant Biosciences Business Overview
11.10.3 Leadiant Biosciences Amphotericin B Introduction
11.10.4 Leadiant Biosciences Revenue in Amphotericin B Business (2019-2024)
11.10.5 Leadiant Biosciences Recent Development
11.11 Kadmon Corporation (Eli Lilly and Company)
11.11.1 Kadmon Corporation (Eli Lilly and Company) Company Detail
11.11.2 Kadmon Corporation (Eli Lilly and Company) Business Overview
11.11.3 Kadmon Corporation (Eli Lilly and Company) Amphotericin B Introduction
11.11.4 Kadmon Corporation (Eli Lilly and Company) Revenue in Amphotericin B Business (2019-2024)
11.11.5 Kadmon Corporation (Eli Lilly and Company) Recent Development
11.12 InterMune
11.12.1 InterMune Company Detail
11.12.2 InterMune Business Overview
11.12.3 InterMune Amphotericin B Introduction
11.12.4 InterMune Revenue in Amphotericin B Business (2019-2024)
11.12.5 InterMune Recent Development
11.13 Sterimax Inc
11.13.1 Sterimax Inc Company Detail
11.13.2 Sterimax Inc Business Overview
11.13.3 Sterimax Inc Amphotericin B Introduction
11.13.4 Sterimax Inc Revenue in Amphotericin B Business (2019-2024)
11.13.5 Sterimax Inc Recent Development
11.14 X-GEN Pharmaceuticals
11.14.1 X-GEN Pharmaceuticals Company Detail
11.14.2 X-GEN Pharmaceuticals Business Overview
11.14.3 X-GEN Pharmaceuticals Amphotericin B Introduction
11.14.4 X-GEN Pharmaceuticals Revenue in Amphotericin B Business (2019-2024)
11.14.5 X-GEN Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Amphotericin B Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Static Drops
Table 3. Key Players of Atomization Inhalation
Table 4. Key Players of Local Lesion Injection
Table 5. Key Players of Other
Table 6. Global Amphotericin B Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Amphotericin B Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Amphotericin B Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Amphotericin B Market Share by Region (2019-2024)
Table 10. Global Amphotericin B Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Amphotericin B Market Share by Region (2025-2030)
Table 12. Amphotericin B Market Trends
Table 13. Amphotericin B Market Drivers
Table 14. Amphotericin B Market Challenges
Table 15. Amphotericin B Market Restraints
Table 16. Global Amphotericin B Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Amphotericin B Market Share by Players (2019-2024)
Table 18. Global Top Amphotericin B Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amphotericin B as of 2023)
Table 19. Ranking of Global Top Amphotericin B Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Amphotericin B Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Amphotericin B Product Solution and Service
Table 23. Date of Enter into Amphotericin B Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Amphotericin B Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Amphotericin B Revenue Market Share by Type (2019-2024)
Table 27. Global Amphotericin B Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Amphotericin B Revenue Market Share by Type (2025-2030)
Table 29. Global Amphotericin B Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Amphotericin B Revenue Market Share by Application (2019-2024)
Table 31. Global Amphotericin B Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Amphotericin B Revenue Market Share by Application (2025-2030)
Table 33. North America Amphotericin B Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Amphotericin B Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Amphotericin B Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Amphotericin B Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Amphotericin B Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Amphotericin B Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Amphotericin B Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Amphotericin B Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Amphotericin B Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Amphotericin B Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Amphotericin B Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Amphotericin B Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Amphotericin B Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Amphotericin B Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Amphotericin B Market Size by Country (2025-2030) & (US$ Million)
Table 48. Bristol-Myers Squibb Company Detail
Table 49. Bristol-Myers Squibb Business Overview
Table 50. Bristol-Myers Squibb Amphotericin B Product
Table 51. Bristol-Myers Squibb Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 52. Bristol-Myers Squibb Recent Development
Table 53. Matinas BioPharma Company Detail
Table 54. Matinas BioPharma Business Overview
Table 55. Matinas BioPharma Amphotericin B Product
Table 56. Matinas BioPharma Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 57. Matinas BioPharma Recent Development
Table 58. Nanox Company Detail
Table 59. Nanox Business Overview
Table 60. Nanox Amphotericin B Product
Table 61. Nanox Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 62. Nanox Recent Development
Table 63. Nanomerics Company Detail
Table 64. Nanomerics Business Overview
Table 65. Nanomerics Amphotericin B Product
Table 66. Nanomerics Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 67. Nanomerics Recent Development
Table 68. DNDi Company Detail
Table 69. DNDi Business Overview
Table 70. DNDi Amphotericin B Product
Table 71. DNDi Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 72. DNDi Recent Development
Table 73. Abzena Company Detail
Table 74. Abzena Business Overview
Table 75. Abzena Amphotericin B Product
Table 76. Abzena Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 77. Abzena Recent Development
Table 78. Bharat Serums Company Detail
Table 79. Bharat Serums Business Overview
Table 80. Bharat Serums Amphotericin B Product
Table 81. Bharat Serums Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 82. Bharat Serums Recent Development
Table 83. Jina Pharma Company Detail
Table 84. Jina Pharma Business Overview
Table 85. Jina Pharma Amphotericin B Product
Table 86. Jina Pharma Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 87. Jina Pharma Recent Development
Table 88. Astellas Pharma Company Detail
Table 89. Astellas Pharma Business Overview
Table 90. Astellas Pharma Amphotericin B Product
Table 91. Astellas Pharma Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 92. Astellas Pharma Recent Development
Table 93. Leadiant Biosciences Company Detail
Table 94. Leadiant Biosciences Business Overview
Table 95. Leadiant Biosciences Amphotericin B Product
Table 96. Leadiant Biosciences Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 97. Leadiant Biosciences Recent Development
Table 98. Kadmon Corporation (Eli Lilly and Company) Company Detail
Table 99. Kadmon Corporation (Eli Lilly and Company) Business Overview
Table 100. Kadmon Corporation (Eli Lilly and Company) Amphotericin B Product
Table 101. Kadmon Corporation (Eli Lilly and Company) Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 102. Kadmon Corporation (Eli Lilly and Company) Recent Development
Table 103. InterMune Company Detail
Table 104. InterMune Business Overview
Table 105. InterMune Amphotericin B Product
Table 106. InterMune Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 107. InterMune Recent Development
Table 108. Sterimax Inc Company Detail
Table 109. Sterimax Inc Business Overview
Table 110. Sterimax Inc Amphotericin B Product
Table 111. Sterimax Inc Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 112. Sterimax Inc Recent Development
Table 113. X-GEN Pharmaceuticals Company Detail
Table 114. X-GEN Pharmaceuticals Business Overview
Table 115. X-GEN Pharmaceuticals Amphotericin B Product
Table 116. X-GEN Pharmaceuticals Revenue in Amphotericin B Business (2019-2024) & (US$ Million)
Table 117. X-GEN Pharmaceuticals Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amphotericin B Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Amphotericin B Market Share by Type: 2023 VS 2030
Figure 3. Static Drops Features
Figure 4. Atomization Inhalation Features
Figure 5. Local Lesion Injection Features
Figure 6. Other Features
Figure 7. Global Amphotericin B Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Amphotericin B Market Share by Application: 2023 VS 2030
Figure 9. Vaginitis Case Studies
Figure 10. Candida Infection Case Studies
Figure 11. Leishmaniasis Case Studies
Figure 12. Kala-Azar Case Studies
Figure 13. Cryptococcal Infection Case Studies
Figure 14. Aspergillus Infection Case Studies
Figure 15. Other Case Studies
Figure 16. Amphotericin B Report Years Considered
Figure 17. Global Amphotericin B Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Amphotericin B Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Amphotericin B Market Share by Region: 2023 VS 2030
Figure 20. Global Amphotericin B Market Share by Players in 2023
Figure 21. Global Top Amphotericin B Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amphotericin B as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Amphotericin B Revenue in 2023
Figure 23. North America Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Amphotericin B Market Share by Country (2019-2030)
Figure 25. United States Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Amphotericin B Market Share by Country (2019-2030)
Figure 29. Germany Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Amphotericin B Market Share by Region (2019-2030)
Figure 37. China Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Amphotericin B Market Share by Country (2019-2030)
Figure 45. Mexico Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Amphotericin B Market Share by Country (2019-2030)
Figure 49. Turkey Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Amphotericin B Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 52. Matinas BioPharma Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 53. Nanox Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 54. Nanomerics Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 55. DNDi Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 56. Abzena Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 57. Bharat Serums Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 58. Jina Pharma Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 59. Astellas Pharma Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 60. Leadiant Biosciences Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 61. Kadmon Corporation (Eli Lilly and Company) Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 62. InterMune Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 63. Sterimax Inc Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 64. X-GEN Pharmaceuticals Revenue Growth Rate in Amphotericin B Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
